Your institution may have access to this item. Find your institution then sign in to continue.
Title
Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis.
Authors
Radstake, T R D J; Svenson, M; Eijsbouts, A M; van den Hoogen, F H J; Enevold, C; van Riel, P L C M; Bendtzen, K
Abstract
Tumour necrosis factor alpha (TNFalpha) neutralising antibody constructs are increasingly being used to treat rheumatoid arthritis (RA).
Publication
Annals of the rheumatic diseases, 2009, Vol 68, Issue 11, p1739